CClinicalTrials.gg
RecruitingNCT07729449Updated Jul 27, 2026

Predictive Value of ONSD and NIRS for PDPH

An observational study in Post-Dural Puncture Headache and Spinal Anesthetics Causing Adverse Effects in Therapeutic Use, sponsored by Ordu University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Ordu University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
44
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Currently, there is no reliable and effective method available in clinical practice to predict the development of PDPH. Early prediction and prevention of PDPH would reduce the incidence of postoperative complications, thereby enhancing the quality of recovery and care for both the mother and the newborn.

In this study, by testing the hypothesis that ONSD changes occurring after spinal anesthesia in pregnant women scheduled for elective cesarean delivery are associated with the development of PDPH, a predictive cutoff value for ONSD will be determined to foresee this complication. As a secondary endpoint, we aimed to evaluate the monitoring of cerebral desaturation secondary to post-spinal hypotension via NIRS and to assess the clinical significance of these data in predicting the development of PDPH.

Read the detailed description

Postdural puncture headache (PDPH) is defined as a headache that develops within five days following a dural puncture, is fundamentally caused by cerebrospinal fluid (CSF) leakage, and is characterized by neck stiffness, photophobia, and/or auditory symptoms. All cases involving a dural puncture during neuraxial block procedures are at risk for developing PDPH. The reported incidence following spinal anesthesia varies widely, ranging from 1% to 36% .The widespread use of neuraxial techniques in obstetric surgery has led to this complication being observed more frequently, particularly in the young female population.

Any delay in diagnosis or treatment can lead to serious, potentially life-threatening complications such as postpartum major depression, visual impairments, cranial nerve palsies, and subdural hematoma. PDPH and its associated complications not only reduce the mother's quality of life but also negatively impact the newborn care process.

The underlying factor in the accepted hypotheses regarding the pathophysiology of PDPH is excessive CSF loss. Changes in CSF volume can lead to changes in optic nerve sheath diameter (ONSD), which is surrounded by the meninges (arachnoid and dura). Due to the free exchange of CSF between the subarachnoid space and this region, changes in fluid volume result in the expansion or narrowing of the ONSD.

The validity of ultrasound-guided ONSD measurement in assessing intracranial pressure has been demonstrated; as a noninvasive and safe option, this method is utilized as a supportive tool for clinical diagnosis. The strong correlation between CSF pressure and ONSD dynamics highlights the potential of perioperative ONSD measurements in predicting the development of PDPH. This approach may carry clinical significance for patients presenting with high-risk factors, such as the use of a large-gauge needle, a low body mass index, and a prior history of headache or PDPH.

Following a decrease in intracranial CSF pressure, changes are also observed in cerebral vascular circulation. Under the Monro-Kellie doctrine, adenosine-mediated vasodilation occurs in vascular structures to compensate for the decreased CSF volume and lower intracranial pressure (ICP), leading to an increase in cerebral blood volume. Under physiological conditions, this compensatory vasodilation is expected to support cerebral blood flow (CBF), thereby maintaining or increasing cerebral oxygen saturation.

However, spinal anesthesia, which is frequently preferred in cesarean delivery, leads to post-spinal hypotension in 70-80% of cases due to the accompanying sympathetic blockade and systemic vasodilation in the lower extremities. Consequently, venous return and cardiac output decrease, leading to a reduction in systemic perfusion pressure. Therefore, although the Monro-Kellie doctrine triggers intracranial vasodilation (and theoretically increases cerebral blood volume), the concurrently developing severe post-spinal systemic hypotension may exceed the limits of cerebral autoregulation, setting the stage for a drop in net cerebral perfusion pressure and CBF velocity. This conflicting physiological process may lead to cerebral desaturation when compensatory mechanisms prove insufficient.

Currently, there is no reliable and effective method available in clinical practice to predict the development of PDPH. Early prediction and prevention of PDPH would reduce the incidence of postoperative complications, thereby enhancing the quality of recovery and care for both the mother and the newborn.

In this study, by testing the hypothesis that ONSD changes occurring after spinal anesthesia in pregnant women scheduled for elective cesarean delivery are associated with the development of PDPH, a predictive cutoff value for ONSD will be determined to foresee this complication. As a secondary endpoint, we aimed to evaluate the monitoring of cerebral desaturation secondary to post-spinal hypotension via NIRS and to assess the clinical significance of these data in predicting the development of PDPH.

02

Conditions studied

  • Post-Dural Puncture Headache
  • Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

Keywords

  • Cesarean Sections
  • Spinal Anesthesia
  • Low Blood Pressure
  • Regional Cerebral Blood Flow
  • Post-Dural Puncture Headache
03

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women aged 18-40 years who are scheduled to undergo elective cesarean section under spinal anesthesia at the tertiary care hospital.

Inclusion criteria

  • Patients aged 18-40 years,
  • American Society of Anesthesiologists (ASA) physical status classification of II or III,
  • Beyond 37 weeks of gestation,
  • Elective cesarean delivery,
  • Provided written informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing emergency cesarean delivery
  • Presence of preoperative anxiety [State-Trait Anxiety Inventory (STAI) - I] score > 30)
  • Presence of preoperative anemia (Hemoglobin \< 11 g/dL),
  • History of hypertension, gestational hypertension, hyperthyroidism, or preeclampsia/eclampsia,
  • Presence of fetal and/or placental anomalies,
  • Known neurological, psychiatric, cardiovascular, or muscular diseases,
  • Chronic headache,
  • Active ocular disease or optic nerve damage,
  • Allergies to local anesthetics or other medications,
  • Requirement for intraoperative general anesthesia,
  • Presence of contraindications to neuraxial anesthesia or conversion to intraoperative general anesthesia,
  • Multiple puncture attempts during spinal anesthesia administration,
  • Development of postpartum hemorrhage.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
44 participants (estimated)
Patient registry
No

Groups and cohorts

  • PDPH Group

    Pregnant women undergoing elective cesarean section under spinal anesthesia who developed post-dural puncture headache (PDPH). Patients will be evaluated for the development of PDPH during the first 5 postoperative days. Inpatients will be assessed in their hospital rooms, while discharged patients will be followed up via daily telephone visits to determine the group placement.

  • Non-PDPH Group

    Pregnant women undergoing elective cesarean section under spinal anesthesia who did not develop post-dural puncture headache (PDPH). Patients will be evaluated for the development of PDPH during the first 5 postoperative days. Inpatients will be assessed in their hospital rooms, while discharged patients will be followed up via daily telephone visits to determine the group placement.

05

What researchers measure

Primary outcomes

  1. Perioperative Optic Nerve Sheath Diameter (ONSD) Changes

    Optic nerve sheath diameter (ONSD) measurements will be performed in patients in the supine position using a 7.5 megahertz linear ultrasound probe by an anesthesiologist with at least three years of experience and over one hundred procedure experiences. Imaging will be obtained in a plane perpendicular to the optic nerve axis through a thin layer of gel applied over closed eyelids. Measurements will be performed 3 mm behind the optic papilla, based on the outer hypoechoic margins. At the determined time points during the perioperative period, the arithmetic mean of a total of four measurements obtained in both transverse and sagittal planes for each eye will be recorded in the data tracking form as the final ONSD value. Optic nerve sheath diameter (ONSD) measurements (in mm) assessed via transorbital ultrasonography to evaluate its predictive value for the development of post-dural puncture headache (PDPH).

    Time frame: Baseline (before spinal anesthesia), 10 minutes after spinal anesthesia, end of surgery, and 24 hours postoperatively

Secondary outcomes

  1. Cerebral Oxygenation (rSO2) Changes

    The incidence of cerebral desaturation following spinal anesthesia will be monitored. Cerebral oxygen saturation (R-NIRS and L-NIRS) will be continuously monitored using NIRS. A decrease in any of the NIRS values of 20% or more relative to baseline within the first 20 minutes will be defined as "cerebral desaturation." In the event of cerebral desaturation, oxygen support will first be optimized; after ruling out potential mechanical factors and bleeding, a norepinephrine infusion will be initiated to optimize cerebral perfusion pressure. The total amount of norepinephrine consumption will be recorded in the data tracking form. Cerebral Oxygenation values will be recorded in the data form every 3 minutes for the first 15 minutes following spinal anesthesia, and every 5 minutes during the remainder of the intraoperative period.

    Time frame: intraoperative period

  2. The Incidence of Post-spinal Hypotension

    The incidence of post-spinal hypotension will be recorded. Post-spinal hypotension will be defined as a decrease in MAP of 20% or more relative to baseline, or an absolute mean arterial pressure (MAP) value falling below 65 mmHg within the first 20 minutes following spinal anesthesia. In patients who develop hypotension, normotension will be targeted using hydration and administration of ephedrine/norepinephrine, and the total amounts of vasopressors (ephedrine and norepinephrine) administered will be recorded in the data tracking form. MAP values will be recorded in the data form every 3 minutes for the first 15 minutes following spinal anesthesia, and every 5 minutes during the remainder of the intraoperative period.

    Time frame: intraoperative period

06

Study locations

1 of 1 sites recruiting
  • Name: Ordu University Training and Research Hospital
    Ordu, Altinordu 52200, Turkey (Türkiye)
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07729449
Lead sponsor
Ordu University
Responsible party
Yasir Ilyas, MD (Assistant Professor, Ordu University) — Principal investigator
First posted
Jul 27, 2026
Start date
Jun 19, 2026
Primary completion
Jun 14, 2027 (estimated)
Completion
Jun 19, 2027 (estimated)
Last update
Jul 27, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion